DEVELOPMENT OF PRODRUGS POSSESSING A NITRIC OXIDE DONOR DIAZEN-1-IUM-1,2-DIOLATE MOIETY USING IN VITRO/IN SILICO PREDICTIONS - Patent 1934872

(19)

(11)

EP 1 934 872 A2

(12)

(43)	Date of publication:
	25.06.2008 Bulletin 2008/26

(21)	Application number: 06826028.0

(22)	Date of filing: 13.10.2006

(51)

International Patent Classification (IPC):

G06F 19/00^(2006.01)

(86)	International application number:
	PCT/US2006/040382

(87)	International publication number:
	WO 2007/044963 (19.04.2007 Gazette 2007/16)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA HR MK RS

(30)

Priority:

13.10.2005 US 726530 P
21.10.2005 US 730120 P
05.01.2006 US 756446 P
09.06.2006 US 812230 P

(71)	Applicant: Novokin Biotech Inc.
	Edmonton AB T6N 1G1 (CA)

(72)	Inventors:
	TAM, Yun, Kau N.t. Hongkong (CN) DIAPER, Christopher, Mark Edmonton, Alberta, T6A 0H4 (CA) SEMPLE, Hugh, A. Edmonton, Alberta, T6G 0G6 (CA) RIDGWAY, Douglas, Thacher Edmonton, Alberta, T6G 3V3 (CA) LIN, Yi-chan, James Edmonton, Alberta, T6H 4M9 (CA) SLOLEY, Brian, Duff Edmonton, Alberta, T5W 4E4 (CA)

(74)	Representative: Lecca, Patricia S.
	Cabinet Lecca 21 rue de Fécamp 75012 Paris 75012 Paris (FR)

(54)	DEVELOPMENT OF PRODRUGS POSSESSING A NITRIC OXIDE DONOR DIAZEN-1-IUM-1,2-DIOLATE MOIETY USING IN VITRO/IN SILICO PREDICTIONS